AzTrials
AzTrials

Substance UseNCT04572126

Feasibility and Efficacy of a Brief Mindfulness-Based Intervention SMOKING INTERVENTION VIA THE INTERNET

A study testing Mindfulness Intervention in people with Substance Use and Smoking Reduction, run by Wayne State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The current study will examine both the feasibility and efficacy of a single session, web-based mindfulness-based intervention for smoking cessation. The study will explore (1) participants' subjective experiences of the intervention, (2) cravings and negative affect both before and after the intervention, and (3)… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Substance Use, Smoking Reduction
What is being tested?
Mindfulness Intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteUnited States
Study dates
25 Nov 2020to 1 Aug 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Daily Smoker
  • Has a desire to quit or reduce smoking.
  • Is not currently involved in another smoking reduction or cessation program.

Who cannot join

  • -

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Wayne State University

    Detroit, Michigan, 48202

Other trials in United States

About this study

Official title: Feasibility and Efficacy of a Brief Mindfulness-Based Smoking Intervention Via the Internet

The current study will examine both the feasibility and efficacy of a single session, web-based mindfulness-based intervention for smoking cessation. The study will explore (1) participants' subjective experiences of the intervention, (2) cravings and negative affect both before and after the intervention, and (3) changes in tobacco use one week and one month following the initial intervention. Further, the study will examine how often participants utilize the intervention between the initial study and follow-up periods.

Being tested
Mindfulness Intervention, Control Intervention
Keywords
Smoking Reduction
Medical subject headings
Substance-Related Disorders, Smoking Reduction

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Mindfulness InterventionBehavioural

    The mindfulness intervention includes strategies to cope with substance cravings based on previously published mindfulness techniques. Examples of strategies presented include paying close attention to sensations, acceptance of cravings, and self-kindness.

  • Control InterventionBehavioural

    The control intervention instructs participants to utilize their own, previously used strategies to cope with substance cravings.

Study groups in NCT04572126
Study groupRoleWhat they receive
Mindfulness GroupExperimentalParticipants in the mindfulness group will receive mindfulness based instructions.
Receives: Behavioral: Mindfulness Intervention
Control GroupActive comparatorParticipants in the control group will receive instructions to cope with cravings how they normally would.
Receives: Behavioral: Control Intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Subjective Ratings Questionnaire

    The participant's ratings of subjective likeability and helpfulness of the intervention. These ratings will be measured on a 5-point Likert Scale with higher scores representing more likeability and helpfulness. The 11-item questionnaire results in a score ranging from 11-55.

    Measured: Immediately post-intervention

  2. Change in Past Month Cigarette and E-Cigarette use.

    An online version of the TLFB (Sobbel \& Sobbel, 1992) will be used to measure past-month cigarette and e-cigarette use. The measure will be administered pre-intervention and one-month following the intervention to show change over time.

    Measured: Immediately before the intervention and at one-month follow-up.

  3. Change in Cigarette/E-cigarette Craving

    Craving to smoke will be measured using the 10-item Brief Questionnaire of Smoking Urges (Cox, Tiffany, \& Christen, 2001).While the QSU-brief can be scored by using all 10 items for one total craving score, maximum likelihood factor analysis of the QSU-brief revealed a two-factor model consisting of (1) a strong desire and intention to smoke with the perception of receiving positive rewards from smoking and (2) the expectation that smoking would relieve negative affect and the strong desire to smoke. The measure will be administered immediately preceding and following the intervention to show intervention influence on craving.

    Measured: Immediately preceding and following intervention.

  4. Change in Positive and Negative Affect

    Positive and negative affect will be measured by the Positive and Negative Affect Schedule (Watson \& Clark, 1999).

    Measured: Immediately preceding and following intervention as well as at one-month follow-up.

Secondary outcomes (1)
  1. Intervention Use.

    Number of times participants viewed intervention between intervention completion and one-month follow-up.

    Measured: One-month after intervention.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Oct 2020
  2. Study start25 Nov 2020
  3. Primary completion20 Jul 2021
  4. Study completion1 Aug 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants are randomly assigned to either the mindfulness intervention group or control group.
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04572126
Sponsor's protocol ID
IRB-20-09-2668
Status last verified
Feb 2022
First submitted
21 Sep 2020
Last updated
11 Mar 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Bowen S, Marlatt A. Surfing the urge: brief mindfulness-based intervention for college student smokers. Psychol Addict Behav. 2009 Dec;23(4):666-71. doi: 10.1037/a0017127.

    PubMed 20025372
  • Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, Carroll KM, Rounsaville BJ. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80. doi: 10.1016/j.drugalcdep.2011.05.027. Epub 2011 Jul 1.

    PubMed 21723049
  • Witkiewitz K, Bowen S. Depression, craving, and substance use following a randomized trial of mindfulness-based relapse prevention. J Consult Clin Psychol. 2010 Jun;78(3):362-374. doi: 10.1037/a0019172.

    PubMed 20515211

Questions about this trial

What is this clinical trial studying?

A study testing Mindfulness Intervention in people with Substance Use and Smoking Reduction, run by Wayne State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Mar 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Subjective Ratings Questionnaire (time frame: Immediately post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04572126, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Mar 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in